Why this biotech’s new-school opioid is on hold with the FDA For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | August 30, 2019 The San Francisco company’s opioid would be the first painkiller of its kind to win FDA approval in a half-century. Posted in Sacramento Business Journal